Lipid droplets (LDs) are ubiquitous organelles in eukaryotic cells that organize and store cellular lipids, including triacylglycerols (TGs), which provide stores of energy and sources of membrane lipids. Despite recent advances in understanding LD biology in cellular physiology and disease, most fundamental key questions about LDs remain unanswered. In this proposal, we focus on the most basic question of determining the mechanisms underlying LD formation. To do so, Aims 1 and 2 will employ a novel system we developed, in which LD formation is induced on a null background in mammalian cells. We accomplish this by inducing acyl CoA: diacylglycerol acyltransferase (DGAT) 1 or DGAT2, which catalyze TG synthesis and lie just upstream to the process of LD formation. By inducing LD formation in cels, we will address key questions: How is TG synthesis coordinated with newly forming LDs? Where in the cell do LDs form? How do monolayer-bound LDs form from bilayer membranes? Specifically, Aim 1 focuses on determining the localization and activity of DGAT enzymes before, during, and at later stages of LD formation.
Aim 2 focuses on determining where LD formation occurs in the cell, how LD formation relates to membrane topology, tubular (or curved) ER, and how TGs in the ER are organized during LD formation.
The final aim focuses on our findings that specific proteins, such as the hepatitis C Core protein, are apparently targeted to newly forming LDs.
Aim 3 therefore will elucidate the mechanism that underlies the targeting of Core to LDs and will identify other endogenous cellular proteins that gain access to LDs through this mechanism. Our studies will provide fundamental knowledge about LDs and cellular lipid metabolism. Additionally, a better understanding of LD formation may have therapeutic implications for diseases of LD excess, such as obesity, diabetes, and atherosclerosis, and may have practical applications in engineering plants and microorganisms for increased oil production.
Metabolic diseases of fat excess, such as obesity, type 2 diabetes, and atherosclerosis, are hugely prevalent disorders. The excess fat in these disorders is stored in cells in fat droplets or lipid droplets. Remarkably little is known about this aspect of cell biology. Our studies are focused on understanding the basic biology that underlies how fat droplets are formed in cells. Our work will lead to a greater understanding of diseases of fat excess and may lead to new therapies.
|Fu, Dan; Yu, Yong; Folick, Andrew et al. (2014) In vivo metabolic fingerprinting of neutral lipids with hyperspectral stimulated Raman scattering microscopy. J Am Chem Soc 136:8820-8|
|Wilfling, Florian; Haas, Joel T; Walther, Tobias C et al. (2014) Lipid droplet biogenesis. Curr Opin Cell Biol 29:39-45|
|Wilfling, Florian; Thiam, Abdou Rachid; Olarte, Maria-Jesus et al. (2014) Arf1/COPI machinery acts directly on lipid droplets and enables their connection to the ER for protein targeting. Elife 3:e01607|
|Currie, Erin; Guo, Xiuling; Christiano, Romain et al. (2014) High confidence proteomic analysis of yeast LDs identifies additional droplet proteins and reveals connections to dolichol synthesis and sterol acetylation. J Lipid Res 55:1465-1477|
|Wilfling, Florian; Wang, Huajin; Haas, Joel T et al. (2013) Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets. Dev Cell 24:384-99|
|Krahmer, Natalie; Hilger, Maximiliane; Kory, Nora et al. (2013) Protein correlation profiles identify lipid droplet proteins with high confidence. Mol Cell Proteomics 12:1115-26|
|Surma, Michal A; Klose, Christian; Peng, Debby et al. (2013) A lipid E-MAP identifies Ubx2 as a critical regulator of lipid saturation and lipid bilayer stress. Mol Cell 51:519-30|
|Currie, Erin; Schulze, Almut; Zechner, Rudolf et al. (2013) Cellular fatty acid metabolism and cancer. Cell Metab 18:153-61|